Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Companies 1/25
Result 56 decisions over 120 months
Reset filters
Minimum amount ? Share of their own holding ?
What the chief executive holds ?
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
8 Sep 2026
Director
Sold on a plan
20,000
$798.00K
31.8%
28 Aug 2026
President & Immunovant CEO
Sold on a plan
200,000
$7.15M
11.1%
27 Jul 2026
President & Immunovant CEO
Sold on a plan
200,000
$6.99M
11.0%
30 Jun 2026
Director
Sold on a plan
10,000
$349.00K
18.9%
29 Jun 2026
Director
Sold on a plan
17,750
$610.25K
51.9%
24 Jun 2026
President & Immunovant CEO
Sold on a plan
200,000
$6.63M
11.0%
22 May 2026
President & Immunovant CEO
Sold on a plan
200,000
$6.05M
11.0%
20 Apr 2026
President & Immunovant CEO
Sold on a plan
200,000
$5.92M
10.8%
17 Mar 2026
President & Immunovant CEO
Sold on a plan
200,000
$5.65M
10.8%
23 Feb 2026
President and Vant Chair
Sold on a plan
587,390
$16.16M
4.1%
20 Feb 2026
President and Vant Chair
Sold on a plan
1,012,610
$27.49M
6.9%
19 Feb 2026
President and Vant Chair
Sold on a plan
1,400,000
$38.39M
9.2%
13 Feb 2026
President & Immunovant CEO
Sold on a plan
200,000
$5.30M
10.8%
12 Jan 2026
President & Immunovant CEO
Sold on a plan
200,000
$4.38M
10.8%
9 Dec 2025
President & Immunovant CEO
Sold on a plan
200,000
$4.17M
11.8%
7 Nov 2025
President & Immunovant CEO
Sold on a plan
200,000
$4.04M
11.7%
17 Oct 2025
President & Immunovant CEO
Sold on a plan
118,418
$2.02M
7.3%
16 Oct 2025
President & Immunovant CEO
Sold on a plan
318,282
$5.43M
17.5%
15 Oct 2025
President & Immunovant CEO
Sold on a plan
414,683
$7.02M
21.6%
13 Oct 2025
President & Immunovant CEO
Sold on a plan
20,727
$336.81K
1.4%
9 Oct 2025
President & Immunovant CEO
Sold on a plan
104,940
$1.71M
6.5%
8 Oct 2025
President & Immunovant CEO
Sold on a plan
138,602
$2.25M
8.4%
7 Oct 2025
President & Immunovant CEO
Sold on a plan
355,161
$5.74M
19.1%
6 Oct 2025
President & Immunovant CEO
Sold on a plan
171,396
$2.80M
10.2%
23 Sep 2025
President & Immunovant CEO
Sold on a plan
611,000
$9.06M
28.9%
22 Sep 2025
President & Immunovant CEO
Sold on a plan
416,182
$6.24M
16.4%
19 Sep 2025
President & Immunovant CEO
Sold on a plan
683,818
$10.22M
25.8%
20 Aug 2025
President & Immunovant CEO
Sold on a plan
100,000
$1.17M
5.7%
21 Jul 2025
President & Immunovant CEO
Sold on a plan
100,000
$1.15M
6.4%
20 Jun 2025
President & COO
Sold on a plan
100,000
$1.15M
6.4%
20 May 2025
President & COO
Sold on a plan
100,000
$1.10M
8.5%
21 Apr 2025
President & COO
Sold on a plan
100,000
$1.02M
8.2%
24 Mar 2025
President & COO
Sold on a plan
434,478
$4.70M
27.8%
20 Mar 2025
President & COO
Sold on a plan
315,522
$3.49M
24.7%
21 Jan 2025
President & COO
Sold on a plan
100,000
$1.13M
12.0%
20 Dec 2024
President & COO
Sold on a plan
100,000
$1.15M
14.4%
20 Nov 2024
President & COO
Sold on a plan
100,000
$1.13M
14.2%
23 Sep 2024
CEO
Sold on a plan
1,983,257
$23.38M
10.0%
23 Sep 2024
Chief Accounting Officer
Sold on a plan
250,000
$2.97M
54.4%
9 Feb 2024
President & COO
Sold on a plan
96,950
$1.06M
15.4%
4 Oct 2023
Chief Operating Officer
Sold on a plan
153,027
$1.55M
20.4%
3 Oct 2023
Chief Operating Officer
Sold on a plan
606,221
$6.21M
50.5%
2 Oct 2023
Chief Operating Officer
Sold on a plan
440,752
$4.76M
42.5%
8 May 2023
President & COO
Sold on a plan
61,206
$546.57K
8.3%
4 May 2023
President & COO
Sold on a plan
88,838
$737.36K
11.6%
3 May 2023
President & COO
Sold on a plan
118,760
$997.58K
14.9%
2 May 2023
President & COO
Sold on a plan
109,074
$904.22K
13.9%
2 May 2023
Chief Accounting Officer
Sold on a plan
15,517
$130.65K
7.2%
1 May 2023
Chief Accounting Officer
Sold on a plan
62,219
$533.84K
23.7%
1 May 2023
President & COO
Sold on a plan
61,155
$525.32K
8.3%
Showing 1–50 of 56. Page 1 of 2 Older →